A CDK1 inhibitor was also found to block HPV infection in a dose-dependent manner, suggesting that phosphorylation of NE components by CDK1 and NE breakdown during early prophase is important for HPV nuclear entry and ultimately infection (Pyeon et al., 2009). This evidence concerns the gene CDK1 and infection.